Monkeys Get Autism-like Reactions to MMR & Other Vaccines In University of Pittsburgh Vaccine Study

Someone did perform safety studies the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) should have mandated be performed and vetted BEFORE numerous vaccines were released into the public sector for mass vaccinations.

Lead investigator Laura Hewitson, PhD, probably dropped a bombshell when she and her colleagues completed a macaque monkey (primates) study of the very same vaccines given to children during 1994-1999, i.e., the Measles-Mumps-Rubella (MMR) vaccine and several Thimerosal mercury-containing vaccines injected into children during that time frame when the autism spectrum disorder skyrocketed.

The results of that pilot study were published as a Research Paper in Acta Neurobiological Experimentals in 2010 and titled “Influence of pediatric vaccines on amydgala growth and opioid ligand binding in rhesus macaque infants: A pilot study.” [1] Even though there was alleged controversy revolving around Hewitson’s monkey studies, e.g., charges of conflicts of interest since she filed a claim with the vaccine court on behalf of her child, [2] the information generated needs to be revisited and duplicate studies need to be undertaken. Why haven’t they? Is there too much influence from vaccine makers not to do them? Parents need to make demands on the U.S. Congress to require such safety studies on monkeys be duplicated immediately, plus suspend all mandates on vaccinations until the study results are in. Did Dr Hewitson become another professional persona non-grata because she may have been on the right track?

Congress needs to consider seriously the Hewitson, et al. report that stated:

“Vaccine-exposed and saline-injected control infants [monkeys] underwent MRI and PET imaging at approximately 4 and 6 months of age, representing two specific timeframes within the vaccination schedule. …

“These results suggest that maturational changes in amygdala volume and the binding capacity of [11C]DPN in the amygdala was significantly altered in infant macaques receiving the vaccine schedule.” [1]

That alone should be the explicit reason for duplicating the monkey study with independent non-pharmaceutical industry conflict of interest scientists.